A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
=== Kosher and halal === All Coffee Bean coffees, teas, and the powders used to make other beverages, are certified kosher. As of June 2020, Coffee Bean ended its storewide kosher-only certification for stores and bakery items in Southern California. Storewide kosher certification was ended for Coffee Bean locations in the Las Vegas area months earlier. While Coffee Bean had planned to move away from kosher-only certification to provide more offerings as a phased rollout before the COVID-19 pandemic, the company said the crisis accelerated its plan. Prior to June 2020, all company-owned locations in Southern California were certified kosher. During that time, most in California and Nevada had signed and dated certificates indicating that the entirety of their items were kosher in conformance to the standards of the certifying agency, the Kosher Supervision of America. Even before June 2020, privately owned franchise stores could opt-out of kosher certification. All the company's locations in Singapore and Malaysia are halal.
Jindřich "Henry" Kopeček (born January 27, 1940) is a Czech-American chemist. He is a professor of pharmaceutical chemistry and a professor of biomedical engineering at the University of Utah in Salt Lake City, Utah. Kopeček is also an honorary professor at Sichuan University in Chengdu, China. His research focuses on biorecognition of macromolecules, bioconjugate chemistry, drug delivery systems, self-assembled biomaterials, and drug-free macromolecular therapeutics. Kopeček is regarded as one of the pioneers in development of biomedicinal polymers such as hydrogel implants and design of new polymer-drug conjugates. He was a key figure in a group which created the first clinically tested polymeric cancerostatics (PK1 and PK2). Hydrogels from his laboratory have been in clinical use. He was elected a member of the U.S. National Academy of Engineering in 2011 for contributions to the design of hydrogel biomaterials and polymeric drug delivery systems. In 2018, he was elected Fellow of the National Academy of Inventors. As of July 15, 2021, Kopeček has been cited over 35,000 times, with an h-index of 100, and I-10 index of 408.
Most class III adenylyl cyclases are transmembrane proteins with 12 transmembrane segments. The protein is organized with 6 transmembrane segments, then the C1 cytoplasmic domain, then another 6 membrane segments, and then a second cytoplasmic domain called C2. The important parts for function are the N-terminus and the C1 and C2 regions. The C1a and C2a subdomains are homologous and form an intramolecular 'dimer' that forms the active site. In Mycobacterium tuberculosis and many other bacterial cases, the AC-III polypeptide is only half as long, comprising one 6-transmembrane domain followed by a cytoplasmic domain, but two of these form a functional homodimer that resembles the mammalian architecture with two active sites. In non-animal class III ACs, the catalytic cytoplasmic domain is seen associated with other (not necessarily transmembrane) domains. Class III adenylyl cyclase domains can be further divided into four subfamilies, termed class IIIa through IIId. Animal membrane-bound ACs belong to class IIIa.
=== Chemical === Neptunium has five ionic oxidation states ranging from +3 to +7 when forming chemical compounds, which can be simultaneously observed in solutions. It is the heaviest actinide that can lose all its valence electrons in a stable compound. The most stable state in solution is +5, but the valence +4 is preferred in solid neptunium compounds. Neptunium metal is very reactive. Ions of neptunium are prone to hydrolysis and formation of coordination compounds.
=== Sandmeyer methodology === The Sandmeyer methodology is the oldest and straightforward way for the synthesis of isatin. The method involves the condensation between chloral hydrate and a primary arylamine (e.g. aniline), in the presence of hydroxylamine hydrochloride, in aqueous sodium sulfate to form an α‐isonitrosoacetanilide. Isolation of this intermediate and subsequent electrophilic cyclization promoted by strong acids (e.g. sulfuric acid) furnishes isatin in >75% yield.
Sources: en.wikipedia.org
In 2017, Burger King made a commitment they said would "require chicken suppliers to breed only higher-welfare strains of chickens, reduce the stocking density of the birds, improve light levels and litter quality inside barns, and use controlled atmosphere stunning to render the birds unconscious before slaughter, dramatically improving slaughter methods and the birds' living conditions;" however, a 2023 report from Compassion in World Farming, an animal advocacy organization, said that Burger King had not reported their progress in complying with the commitment, raising fears among animal advocates that the commitment was not being met. Burger King has been praised by animal advocates for the introduction of a Whopper made with a plant-based meat alternative from Impossible Foods and for the introduction of vegan menu items like the "Vegan Royale" in the UK. Burger King UK has pledged to offer a 50% meat-free menu by 2030.
=== Other risk markers === FM prevalence rates appear higher when COVID-19 infections have occurred. Other risk markers for fibromyalgia include or potentially include premature birth, female sex, childhood cognitive and psychosocial problems, primary pain disorders, multiregional pain, infectious illness, hypermobility of joints, iron deficiency, and small-fiber polyneuropathy. Fibromyalgia has also been linked with metal-induced allergic inflammation, especially in response to nickel but also inorganic mercury, cadmium, and lead. A 2022 review found that between 6% and 27% of people with FM reported an infectious inciting event (e.g. Epstein-Barr virus, Lyme disease), with up to 40% describing worsening symptoms after infection.
Zippe-type centrifuges use countercurrent multiplication between rising and falling convection currents to reduce the number of stages needed in a cascade. Some Centrifugal extractors use counter current exchange mechanisms for extracting high rates of the desired material. Some protein skimmers (devices used to clean saltwater pools and fish ponds of organic matter) use counter current technologies. Countercurrent processes have also been used to study the behavior of small animals and isolate individuals with altered behaviors due to genetic mutations.
=== Foreign political and diplomatic figures === Henry Cruger* (1758), member of the Parliament of Great Britain 1774–1790 and the New York State Senate Isaac Wilkins (1760), judge, member of the Nova Scotia House of Assembly Thomas Henry Barclay (1772), United Empire Loyalist; member of the 6th General Assembly of Nova Scotia Tang Shaoyi* (1882), first premier of the Republic of China William Sanford Evans (1895), Manitoba politician, mayor of Winnipeg 1909–1911 Pixley ka Isaka Seme (1906), founder and president of the African National Congress Wellington Koo (1909), president of the Republic of China and China's ambassador to the United States; Chinese delegate to the Paris Peace Conference, 1919 and the League of Nations; judge on the International Court of Justice 1957–1967 Jun Ke Choy (1915), former mayor of Hangzhou, chairman of China Merchants Group, and founder of the Chinese Culture Center Yu Tsune-chi (1922), Chinese ambassador to Italy and Spain, delegate to the San Francisco Conference, United Nations and the International Labour Organization Mario Laserna Pinzón (1948), Colombian diplomat and educator; founded the Universidad de Los Andes Colin Hughes (1949), first commissioner of the Australian Electoral Commission Uldis-Ivars Grava (1958), Latvian parliamentarian, former director of Latvijas Televīzija and chairman of American Latvian Association Johan Jorgen Holst (1960), Norwegian minister of Defence and Foreign Affairs; heavily involved with the Oslo Accords Yossi Alpher (1964), former Mossad officer and director of the Jaffee Center for Strategic Studies at Tel Aviv University Dore Gold (1975), Israeli political advisor and diplomat; former ambassador to the United States Toomas Hendrik Ilves (1975), president of Estonia Carson Wen (1975), three-time Hong Kong deputy to the National People's Congress and former vice chairman of the Democratic Alliance for the Betterment and Progress of Hong Kong Geoffrey Onyeama (1977), Nigerian minister of Foreign Affairs since 2015, son of Nigerian justice Charles Onyeama Michael Oren (1977), Israeli historian and former Israeli ambassador to the United States Miloon Kothari (1979), United Nations special rapporteur on adequate housing Kim Hyun-jong (1981), former South Korean minister of Trade and Special Advisor to President Moon Jae-in Ken Ofori-Atta (1984), Ghanaian economist and investment banker and current minister for Finance and Economic Planning, member of the Ofori-Atta family Akiva Tor (1985), Israeli ambassador to South Korea Abdullah bin Khalid bin Sultan Al Saud (2010), Saudi Arabia's permanent representative to the United Nations in Vienna, ambassador to Austria, Slovakia and Slovenia, great-grandson of Ibn Saud
Sources: en.wikipedia.org
=== Recreational use === 3-MeO-PCP has been more widely reported than many other similar grey market arylcyclohexylamines. 3-MeO-PCP has been available for purchase online as a research chemical. Use has been reported across Europe and the United States. 3-MeO-PCP is usually taken orally or nasally, but can also be injected or smoked. Duration and onset of effects varies depending on route of administration. When taken orally, onset takes 30–90 minutes and effects last 4–8 hours, generally peaking at 2-3 hours. Its effects are described as being similar to related dissociatives such as PCP. Being slightly more potent than PCP, threshold doses starts at 1 mg, with substantial dissociative effects starting at 5 mg. Strong dissociative effects are seen at 10-20 mg. It has been described as producing more euphoria and mental clarity than similar drugs. Negative effects include hypertension, tachycardia, confusion, and disorientation. In one case of an individual taking a very large oral dose (300–500 mg), psychosis and aggressive behaviors, followed by amnesia were observed. As of 2022, there has been two known deaths that can be attributed to 3-MeO-PCP alone; one in Sweden and one in the UK. There were 14 additional deaths where 3-MeO-PCP was detected in the blood post-mortem.
The process typically heats honey to 66–77 °C (150–170 °F) to more easily pass through the filter. Filtered honey is very clear and will not crystallize as quickly, making it preferred by supermarkets. The most common method involves the addition of diatomaceous earth to honey that is heated to 60 °C (140 °F) and passed through filter paper or canvas until a cake of diatomaceous earth builds up on the filter. Ultrasonicated honey has been processed by ultrasonication, a nonthermal processing alternative for honey. When honey is exposed to ultrasonication, most of the yeast cells are destroyed. Those cells that survive sonication generally lose their ability to grow, which reduces the rate of honey fermentation substantially. Ultrasonication also eliminates existing crystals and inhibits further crystallization in honey. Ultrasonically aided liquefaction can work at substantially lower temperatures around 35 °C (95 °F) and can reduce liquefaction time to less than 30 seconds. Creamed honey, also called whipped honey, spun honey, churned honey, honey fondant, and, in the UK, set honey, has been processed to control crystallization. Creamed honey contains a large number of small crystals, which prevent the formation of larger crystals that can occur in unprocessed honey. The processing also produces a honey with a smooth, spreadable consistency. Dried honey has the moisture extracted from liquid honey to create completely solid, nonsticky granules. This process may or may not include the use of drying and anticaking agents.
=== Former markets === Russia – Pizza Hut began operating in Russia in 1991, when food supplies dwindled during the 1991 Soviet coup d'état attempt, prompting Russian president Boris Yeltsin to call Pizza Hut deliveries. Pizza Hut suspended operations in response to the 2022 Russian invasion of Ukraine. Later some restaurants re-opened operations under rebranded new trademark PittsaN (ПиццаН). Panama – In 2022, the Pizza Hut chain ceased its operations in Panamanian lands after reporting economic losses. Argentina – Pizza Hut opened in Argentina in 1983; however, they withdrew some time later. They returned in the mid-1990s but withdrew again in 1998 due to poor sales success. It was announced that it will be brought back to the country in 2025, but the exact date has not been confirmed. Chile – In 2025, the Pizza Hut chain downsized its operations in Chile as one of its two franchising concerns, Food Delivery Brands (which also handled Telepizza), went bankrupt as a result of the economic crisis the country had faced in the past decade and increasing competition from rival chains such as Little Caesars and Papa John's.
==== Australia ==== 2C-B is controlled in Australia and on the list of substances subject to import and export controls (Appendix B). It was placed on Schedule One of the Drugs Misuse and Trafficking Act when it first came to notice in 1994, when in a showcase legal battle chemist R. Simpson was charged with manufacturing the substance in Sydney. Alexander Shulgin came to Australia to testify on behalf of the defense, to no avail. 2C-B is not specifically listed in the Australia Poisons Standard (October 2015), however similar drugs such as 2C-T-2 and 2C-I are making 2C-B fall under the Australian analogue act.
=== Xen and final release (2015–2020) === The release of the Xen part of the game had been the most difficult, since the team wanted to redesign the levels to overcome the poor perception that they had in Half-Life's original release. The team said, "We want our version of Xen to feel like it really belongs with the rest of the game in terms of mechanics, cohesion and progression," while at the same time, they wanted "to push the boundaries and explore this unique and varied setting; to build an experience that feels both fresh and familiar to players from all walks of Half-Life veterancy." Developing their new version of Xen was a chicken-or-the-egg dilemma, as without level design it was difficult to develop art assets, and without art assets it was hard to come up with cohesive level designs. They also wanted to give more story elements there, such as why human scientists were studying the world of Xen in the first place, trying to capture the same type of world-building by level design that Valve had been able to with the first parts of Half-Life. They also significantly reworked the boss battles to be more challenging and representative of the area they had in mind. Ultimately, the team expanded out Xen from about a one-hour experience in the original Half-Life to four hours in Black Mesa.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.